Serotonin Reuptake Inhibitors in Obstructive Sleep Apnea: Associations in People with and without Epilepsy

Table 1

Baseline characteristics.

	-SRI (N=80); N (%)	+SRI (N=45); N (%)	χ^2	p
Gender (male)	44 (55)	26 (58)	0.090	0.764
Hypertension	21 (26)	18 (40)	2.537	0.111
Diabetes	15 (18.75)	11 (24)	0.567	0.451
Congestive Heart Failure	7 (8.75)	3 (6.67)	0.170	0.680
Stroke/TIA	15 (18.75)	8 (17.78)	0.018	0.893
COPD/asthma	13 (16.25)	13 (28.9)	2.793	0.095
Epilepsy	34 (42.5)	23 (51)	0.861	0.353
Focal epilepsy	31 (38.75)	18 (40)	0.019	0.891
Generalized epilepsy	2 (2.5)	2 (4.44)	0.352	0.553
Undetermined epilepsy	1 (1.25)	3 (6.67)	2.728	0.099
Tobacco	4 (5)	0 (0)	2.324	0.127
Alcohol	0 (0)	0 (0)	------	------
Drug Abuse	3 (3.75)	1 (2)	0.217	0.641
Opioids	3 (3.75)	1 (2)	0.217	0.641
Benzodiazepines	17 (21.25)	13 (28.9)	0.921	0.337
Non-benzodiazepines	9 (11.25)	4 (9)	0.172	0.678
AED	41 (51.25)	32 (71.11)	7.898	0.048
	Mean ± SD	Mean ± SD	CI	P
Age (years)	57.73±14.43	62.51±10.36	-9.21-  -0.366	0.034
Body Mass Index	30.86±6.13	30.95±5.91	-2.30-2.14	0.942

SRI: serotonin reuptake inhibitor, TIA: transient ischemic attack, COPD: chronic obstructive pulmonary disease, and AED: antiepileptic drug; : p<0.05.